Results 21 to 30 of about 22,180 (202)

Urinary retention in male patient associated with aripiprazole

Medicine Science, 2016
Urinary retention and / or voiding difficulty are a rare side effect caused by the second generation antipsychotics. Aripiprazole has a lower incidence of adverse effects than other second generation antipsychotics (SGA) and aripiprazole can be used as ...
Lara Utku Ince, Lale Gonenir Erbay, Suheyla Unal   +2 more
doaj   +1 more source

ARIPIPRAZOLE INDUCED COMPULSIVE EATING DISORDER: A CASE REPORT

European Psychiatry, 2023
Introduction Aripiprazole is a newer atypical antipsychotic with a favorable side-effect profile, especially a low propensity to result in metabolic syndromes.It is effective at treating bipolar disorder, the positive symptoms of schizophrenia and has ...
M. Turki, A. Samet, F. Sahnoun, F. Jemil, S. Ellouze, N. Halouani, J. Aloulou   +6 more
doaj   +1 more source

Tardive Dystonia Described as Tardive Tremor. [PDF]

J Gen Fam Med
Journal of General and Family Medicine, Volume 27, Issue 4, July 2026.
Gaber S, Kamo H, Hess CW.
europepmc   +2 more sources

Drug–drug interaction and initial dosage optimization of aripiprazole in patients with schizophrenia based on population pharmacokinetics

Frontiers in Psychiatry
BackgroundThe present study aimed to investigate the drug–drug interaction and initial dosage optimization of aripiprazole in patients with schizophrenia based on population pharmacokinetics.Research design and methodsA total of 119 patients with ...
Cun Zhang, Lei Jiang, Lei Jiang, Ke Hu, Yi-Jia Zhang, Yi-Jia Zhang, Jing Han, Jing Han, Jin Chen, Jin Chen, Bulubu, Bulubu, Boling Dong, Boling Dong, Hao-Zhe Shi, Hao-Zhe Shi, Su-Mei He, Ting-Ting Yu, Xiao Chen, Dong-Dong Wang   +19 more
doaj   +1 more source

Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases

SAGE Open Medical Case Reports, 2017
Objectives: The efficacy of a partial agonist for the dopamine D 2 receptor, aripiprazole, for catatonia in schizophrenia has been reported. Methods: We report distinct clinical courses in challenging aripiprazole to treat residual mutism after severe ...
Katsumasa Muneoka, Nobuhisa Kanahara, Shou Kimura   +2 more
doaj   +1 more source

Persistent hiccups due to aripiprazole: a case report and review of the literature

Frontiers in Pharmacology
Introduction: Aripiprazole, a commonly prescribed antipsychotic, has been rarely associated with the onset of hiccups. This study aims to elucidate the prevalence, risk factors, and management of aripiprazole-induced hiccups.Methods: We report a case of ...
Yaoyin Zhang, Yaoyin Zhang, Wei Chen, Wei Chen, Junming Chen, Junming Chen, Mingmei Li, Mingmei Li, Yulan Huang, Yulan Huang, Wenjiao Min, Wenjiao Min   +11 more
doaj   +1 more source

Effect of Aripiprazole on Anxiety Associated With Ethanol Physical Dependence and on Ethanol-Induced Place Preference

Journal of Pharmacological Sciences, 2012
In the present study, we investigated the effect of aripiprazole, a dopamine system stabilizer, on ethanol-induced psychological and physiological dependence and anxiety-like behavior.
Masahiro Shibasaki, Kazuhiro Kurokawa, Koji Mizuno, Seitaro Ohkuma   +3 more
doaj   +1 more source

Beyond the Outburst: Charting a New Frontier for Understanding and Treating Irritability in Autistic Adults

Autism Research, EarlyView.
ABSTRACT Irritability is a prevalent and impairing feature associated with autism, yet remains poorly understood, particularly in adults. Drawing heavily on insights translated from pediatric and transdiagnostic literatures, we propose that irritability in autistic individuals often reflects a psychophysiological stress or threat response, rooted in a ...
Hsiang‐Yuan Lin, Arthur N. Westover, Amy S. F. Lutz, Manish K. Jha   +3 more
wiley   +1 more source

CYP2C19 Genotype is Associated with Citalopram Treatment Outcomes in a Real‐World Setting

Clinical Pharmacology &Therapeutics, EarlyView.
CYP2C19 metabolizes various selective serotonin reuptake inhibitors (SSRIs) and genetic CYP2C19 variants are associated with SSRI tolerability and response. Yet, whether CYP2C19 variability also impacts citalopram response remained unclear. We here evaluated associations between CYP2C19 genotypes and citalopram prescription data of 11,079 patients from
Yoomi Park, Yitian Zhou, Volker M. Lauschke   +2 more
wiley   +1 more source

Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas

Endocrine Oncology
Prolactinomas are the most common hypersecretory pituitary adenoma. The traditional first-line therapy is dopamine agonists (DAs), which are highly effective and tolerated in the majority of cases.
Edward Mignone, Alistair K Jukes, Rowan Valentine, Richard Allison, Sunita M C De Sousa   +4 more
doaj   +1 more source